Industry reports
Editor highlights

Drug Discovery and Development Industry in Israel: Market Research Reports, Statistics and Analysis

You might be interested in: clinical trial, drug discovery, clinical research, more »

» View Public Reports

42 reports

Can-Fite BioPharma Ltd. - Company Report for Year 2013

  • Company report
  • December 2013
  • 231 pages
  • by Corporation

... Regulatory approvals, as well as commercializing any products approved for sale. Because the outcome of our planned and anticipated clinical trials is highly uncertain, we cannot reasonably estimate the actual ...

Company Report: Drug Discovery and Development in Israel and The United States for Year 2013

  • Company report
  • July 2013
  • 219 pages
  • by Corporation

... We, or our licensees, as applicable, will be required to conduct significant additional clinical trials before we or they can seek the regulatory approvals necessary to begin commercial sales of our ...

Company Report: Drug Discovery and Development in Israel and The United States for Year 2013

  • Company report
  • July 2013
  • 229 pages
  • by Corporation

... We, or our licensees, as applicable, will be required to conduct significant additional clinical trials before we or they can seek the regulatory approvals necessary to begin commercial sales of our ...

Company Report: Drug Discovery and Development in The United States, Denmark and Israel for Year 2013

  • Company report
  • July 2013
  • 17 pages

... That these products will successfully complete clinical trials and/or regulatoy review without significant delays. Failure to fulfill the clinical endpoints of these experiments would force redhill to conduct ...

Pluristem Therapeutics Inc. - Annual Report 2013

  • Company report
  • June 2013
  • 106 pages

Bank of Israel - Company Report for Year 2013

  • Company report
  • February 2013
  • 86 pages
  • by Corporation

... Unforeseen events during, or as a result of, the clinical trial process that could delay or prevent commercialization of our current or future therapeutic cands, including but not limited to ...

Company Report: Drug Discovery and Development in Israel and The United States for Year 2013

  • Company report
  • February 2013
  • 42 pages
  • by Corporation

... And at least one additional ingredient. Contemplated clinical trial Shall mean one of the two non-comparative clinical trials managed by licensor as of the execution date, studying the effects of the drug ...

Compugen Ltd. - Company Report for Year 2013

  • Company report
  • January 2013
  • 26 pages
  • by Corporation

... While continuing to expand and enhance our discovery infrastructure. Pipeline program during 2010, we broadened our approach to drug target and drug discovery, moving from a technology driven ...

Company Report: Drug Discovery and Development in Israel and The United States for Year 2012

  • Company report
  • December 2012
  • 145 pages
  • by Corporation

... And 27 months in the extension trial), patients continued to demonstrate a significant improvement in all parameters with a similar safety profile as seen in the phase iii clinical trial. In the phase ...

Search in Drug Discovery and Development Industry

» Purchase Premium Reports (From $ 125 - $ 3 835)

18 reports
neoLaser - Product Pipeline Analysis, 2013 Update

neoLaser - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • December 2013
  • by Global Data

Summary neoLaser is a medical devices company. The company designs, manufactures and distributes medical laser products. Its products include endovascular kits and neoV. neoLaser also provides neoV 1470, ...

Jetguide Ltd. - Product Pipeline Analysis, 2013 Update

May 2013 $ 750

Neolaser - Product Pipeline Analysis

December 2012 $ 750

Stimatixgi Ltd. - Product Pipeline Analysis

December 2012 $ 750

Drug Discovery And Development: Rescuedose L.t.d.

November 2012 $ 750

Magen Orthomed Ltd. - Product Pipeline Analysis

November 2012 $ 750

Drug Discovery And Development: Jetguide Ltd.

November 2012 $ 750

Drug Discovery And Development: Corassist Cardiovascula ...

June 2012 $ 750

Drug Discovery And Development: Lithotech Medical Ltd.

June 2012 $ 750

Karmelsonix Ltd. (symbol:ksx) Swot Analysis, Strategy, ...

December 2011 $ 125

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.